CYP1A1 - cytochrome P450 family 1 subfamily A member 1 Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 282870
CYP1A1 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_002696635.5 | XP_002696681.1 | cytochrome P450 1A1 |
| XM_005222018.4 | XP_005222075.1 | cytochrome P450 1A1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytochrome P450 1A1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Nom du produit |
Effect
|
Pureté |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0822 | Fipronil | 99.49% | Unkown | |
| HY-B1234 | Octinoxate | 99.84% | Unkown | |
| HY-W017113 | 2-Mercaptobenzothiazole | 99.85% | Yes | |
| HY-B0822R | Fipronil (Standard) | 99.49% | Unkown |
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Nom du produit |
Effect
|
Pureté |
Phase |
|---|---|---|---|---|
| HY-109173 | Filapixant | 99.10% | Phase 2 | |
| HY-16031A | AFP464 | / | Phase 2 | |
| HY-135829 | BAY 2416964 | Antagonist | 99.59% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(94)
| Cat. No. | Nom du produit |
Effect
|
Pureté |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0382 | Galangin | 99.99% | Unkown | |
| HY-19340 | TMS | Inhibitor | 99.40% | Unkown |
| HY-N2194 | Bergamottin | Inhibitor | 99.94% | Unkown |
| HY-N0563 | Alizarin | 99.48% | Unkown | |
| HY-D0145 | 7-Ethoxyresorufin | Inhibitor | 99.61% | Unkown |
| HY-133677 | Mono(2-ethyl-5-hydroxyhexyl) phthalate | 99.03% | Unkown | |
| HY-134217 | KYN-101 | Inhibitor | 98.03% | Unkown |
| HY-Y0110 | 2-Naphthol | 99.91% | Unkown | |
| HY-112628 | CAY10464 | Antagonist | 99.77% | Unkown |
| HY-W007700 | 8-Bromooctanoic acid | 99.89% | Unkown | |
| HY-N2374 | Eupatorin | Inhibitor | 99.53% | Unkown |
| HY-N4205 | Tetrahydropiperine | Inhibitor | 99.41% | Unkown |
| HY-D0932 | Sudan IV | 98.0% | Unkown | |
| HY-N2625A | Harmalol hydrochloride | 99.91% | Unkown | |
| HY-117102 | ANI-7 | Activator | 99.01% | Unkown |
| HY-G0007 | Omeprazole sulfone | Control | 99.23% | Unkown |
| HY-101285 | DMU2139 | Inhibitor | 98.0% | Unkown |
| HY-G0006 | Omeprazole sulfide | 99.88% | Unkown | |
| HY-17663 | KMR-206 | 98.86% | Unkown | |
| HY-22024 | 5-Hydroxyflavone | Substrate | 99.83% | Unkown |
| HY-N1082 | Visnagin | 99.34% | Unkown | |
| HY-124421 | 5F-203 | Inducer | 98.04% | Unkown |
| HY-152118 | CYP1B1-IN-4 | Inhibitor | 99.09% | Unkown |
| HY-B0973 | Dibenzothiophene | Inhibitor | 99.92% | Unkown |
| HY-120377 | CYP1A1 inhibitor 8a | Inhibitor | 98.00% | Unkown |
| HY-124404 | 12(R)-HETE | 99.90% | Unkown | |
| HY-N5132 | (-)-Fenchone | 98.0% | Unkown | |
| HY-159006 | CYP1B1 ligand 3 | Inhibitor | 99.83% | Unkown |
| HY-101284 | DMU2105 | Inhibitor | 99.31% | Unkown |
| HY-103223 | Phortress | Inducer | 98.19% | Unkown |
| HY-146393 | PROTAC CYP1B1 degrader-1 | Inhibitor | 98.09% | Unkown |
| HY-147128 | PY109 | Agonist | 99.15% | Unkown |
| HY-157942 | CYP1B1-IN-7 | Inhibitor | 99.88% | Unkown |
| HY-N8382 | Chalepensin | Inhibitor | 98.98% | Unkown |
| HY-RS03443 | CYP1B1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008003 | 2-Hydroxybenzimidazole | Control | 99.98% | Unkown |
| HY-W713284 | 2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate | 99.87% | Unkown | |
| HY-D0145S | 7-Ethoxyresorufin-d5 | Inhibitor | 98.89% | Unkown |
| HY-Y0110S1 | 2-Naphthol-d7 | 99.37% | Unkown | |
| HY-B0822S1 | Fipronil-13C6 | 98% | Unkown | |
| HY-113040A | (17R,18S)-Epoxyeicosatetraenoic acid | Inhibitor | 93.0% | Unkown |
| HY-118474 | GW 610 | Activator | 99.78% | Unkown |
| HY-N6264 | 26-Deoxyactein | Inhibitor | 99.76% | Unkown |
| HY-W067374 | Aripiprazole impurity 38 | 97.79% | Unkown | |
| HY-118216 | Bitertanol | 98.70% | Unkown | |
| HY-128920 | Phortress free base | Inhibitor | / | Unkown |
| HY-14225 | BMS-764459 | / | Unkown | |
| HY-148592 | Antitumor agent-87 | Inhibitor | / | Unkown |
| HY-148595 | CYP1A1-IN-2 | Inhibitor | / | Unkown |
| HY-150557 | CYP1B1-IN-1 | Inhibitor | / | Unkown |
| HY-150558 | CYP1B1-IN-2 | Inhibitor | / | Unkown |
| HY-152079 | CYP1B1-IN-3 | Inhibitor | / | Unkown |
| HY-152196 | CYP1B1-IN-5 | Inhibitor | 98.03% | Unkown |
| HY-158429 | PROTAC CYP1B1 degrader-2 | Degrader | / | Unkown |
| HY-158430 | CYP1B1 ligand 2 | / | Unkown | |
| HY-161403 | CYP1B1-IN-8 | Inhibitor | / | Unkown |
| HY-162051 | CYP1B1-IN-6 | Inhibitor | / | Unkown |
| HY-16265A | JI-101 hydrochloride | Inhibitor | / | Unkown |
| HY-174425 | CYP1B1-IN-9 | Inhibitor | / | Unkown |
| HY-175554 | CYP1B1-IN-10 | Inhibitor | / | Unkown |
| HY-175760 | CYP1B1-IN-11 | Inhibitor | / | Unkown |
| HY-175836 | CYP1B1-IN-12 | / | Unkown | |
| HY-178053 | AHR agonist 10 | / | Unkown | |
| HY-181472 | 10(11)-Cl-BBQ | / | Unkown | |
| HY-181550A | CYP1B1-IN-14 TFA | Inhibitor | / | Unkown |
| HY-181629 | ZSTK3744 | / | Unkown | |
| HY-181629A | ZSTK3744 hydrochloride | / | Unkown | |
| HY-183304 | Anticancer agent 318 | Substrate | / | Unkown |
| HY-B0973S | Dibenzothiophene-d8 | Inhibitor | / | Unkown |
| HY-G0007S | Omeprazole sulfone-d3 | Control | / | Unkown |
| HY-G0007S1 | Omeprazole sulfone-13C,d3 | Control | / | Unkown |
| HY-N0382R | Galangin (Standard) | / | Unkown | |
| HY-N0382S | Galangin-13C3 | / | Unkown | |
| HY-N10344 | Glucoarabin | Activator | / | Unkown |
| HY-N2689 | (R)-6',7'-Dihydroxybergamottin | Inhibitor | / | Unkown |
| HY-RS03441 | CYP1A1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W762015 | 1,2,3,6,7,8-Hexachlorodibenzofuran | Inducer | / | Unkown |
| HY-Y0110S | 2-Naphthol-d8 | / | Unkown | |
| HY-101284A | (E/Z)-DMU2105 | Inhibitor | / | Unkown |
| HY-126308 | (E/Z)-DMU2139 | Inhibitor | / | Unkown |
| HY-129247 | Versicolorin A | / | Unkown | |
| HY-158431 | (S,R,S)-AHPC-Me-8-bromooctanoic acid | / | Unkown | |
| HY-167632 | meso-Zeaxanthin | 93.09% | Unkown | |
| HY-174333 | CYP1A1-IN-1 | Inhibitor | / | Unkown |
| HY-B1234S | Octinoxate-13C,d3 | / | Unkown | |
| HY-D0932S | Sudan IV-d6 | / | Unkown | |
| HY-N0922 | Methysticin | Activator | / | Unkown |
| HY-RS16737 | Cyp1a1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16945 | Cyp1b1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23174 | Cyp1a1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23388 | Cyp1b1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W472509 | 11-HETE | Activator | / | Unkown |
| HY-W517092 | 1,2,3,4,7,8,9-Heptachlorodibenzofuran | / | Unkown | |
| HY-W775354 | 1,2,3,4,7,8-Hexachlorodibenzofuran | / | Unkown |